HeartMate 3 in Pediatric and Complex Populations: Physiologic Rationale, Patient Selection, and Management Strategies

Area of Science:

• Cardiovascular Surgery
• Pediatric Cardiology
• Medical Device Technology

Background:

• The HeartMate 3 (HM3) left ventricular assist device (LVAD), originally for adults, sees increasing use in pediatric patients, small adults, and those with congenital heart disease (CHD).
• This expanded application necessitates a deeper understanding of the device's unique physiological and management considerations in these specific patient groups.
• Existing knowledge gaps require collaborative efforts to optimize care for these complex cases.

Purpose of the Study:

• To review the key physiologic and management considerations for utilizing the HM3 LVAD in pediatric, small adult, and CHD populations.
• To highlight the importance of understanding device dynamics, preoperative assessment, and postoperative care tailored to these unique patient groups.
• To emphasize the need for a multidisciplinary approach and collaborative data sharing for refining best practices.

Main Methods:

• This is a review article, synthesizing current knowledge and clinical experience.
• It focuses on analyzing the interplay of pump power, flow, and pulsatility index in smaller patients.
• It examines preoperative assessment criteria, postoperative management strategies (including anticoagulation and pain control), and specific considerations for CHD physiologies like Fontan circulation.

Main Results:

• The HM3's design mitigates thrombotic risk, but specific power-flow dynamics and pressure sensitivities in smaller patients require careful attention.
• Individualized preoperative assessments and postoperative management, including anticoagulation and driveline care, are crucial.
• A multidisciplinary approach is essential for managing comorbidities like muscular dystrophy, addressing infection, respiratory issues, and quality of life.

Conclusions:

• Successful implementation of the HM3 LVAD in pediatric and CHD patients hinges on comprehensive patient/family education, rehabilitation, psychosocial support, and meticulous device optimization.
• Continued collaborative sharing of real-world data, especially long-term outcomes, is critical for refining best practices.
• Optimizing support for these complex patients requires ongoing research and a unified clinical strategy.